Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7405061 Antigen PIPA and antibodies that bind thereto

Patent 7405061 was granted and assigned to Raven Biotechnologies on July, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Current Assignee

Raven Biotechnologies

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Jennie P. Mather0

Ronghao Li0

Tony W. Liang0

Date of Patent

July 29, 2008

Patent Application Number

10713248

Date Filed

November 13, 2003

Patent Citations Received

US Patent 11942149 Bispecific binding molecules that are capable of binding CD137 and tumor antigens, and uses thereof

0

US Patent 11685781 Variant CD3-binding domains and their use in combination therapies for the treatment of disease

0

US Patent 11697684 Tri-specific binding molecules that specifically bind to multiple cancer antigens

0

US Patent 11840571 Methods of using bispecific molecules having immunoreactivity with PD-1 and CTLA-4

0

Patent Primary Examiner

Alana M. Harris

Patent abstract

Provided herein is disclosure about the identification and characterization of disease and cancer associated antigen PIPA. The invention also provides a family of monoclonal antibodies that bind to antigen PIPA, and methods of diagnosing and treating various human cancers and diseases that express PIPA.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7405061 Antigen PIPA and antibodies that bind thereto

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool